0001415889-24-003984.txt : 20240215 0001415889-24-003984.hdr.sgml : 20240215 20240215181409 ACCESSION NUMBER: 0001415889-24-003984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240215 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patni Rajiv CENTRAL INDEX KEY: 0001616200 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38890 FILM NUMBER: 24645216 MAIL ADDRESS: STREET 1: C/O OCERA THERAPEUTICS, INC. STREET 2: 525 UNIVERSITY AVENUE, SUITE 610 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quince Therapeutics, Inc. CENTRAL INDEX KEY: 0001662774 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 901024039 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 273 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-910-5717 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 273 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Cortexyme, Inc. DATE OF NAME CHANGE: 20160104 4 1 form4-02152024_110201.xml X0508 4 2024-02-15 0001662774 Quince Therapeutics, Inc. QNCX 0001616200 Patni Rajiv C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BOULEVARD, SUITE 273 SOUTH SAN FRANCISCO CA 94080 true false false false 0 Employee Stock Option (right to buy) 1.30 2024-02-15 4 A 0 54000 0 A 2034-02-15 Common Stock 54000 54000 D The shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of February 15, 2024, subject to the Reporting Person's continued service as a member of the Board of Directors of the Issuer as of each such vesting date. /s/ Brendan Hannah, Attorney-in-Fact 2024-02-15